To explore the pathological significance of ANXA1 in colon cancer, we successively recruited 50 colon cancer patients, of which 25 patients (50%) showed positive expression of ANXA1 for their tumors via immunohistochemistry (Supplementary Table S1). Here, ANXA1 is linked to malignant colon neoplasm.